Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients

NCT02456844 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Montelukast, Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-986142
DRUG: Methotrexate, Leucovorin and BMS-986142

Sponsor

Bristol-Myers Squibb